Bharat Immunologicals (India) Performance

Bharat Immunologicals holds performance score of 20 on a scale of zero to a hundred. The firm shows Beta (market volatility) of 1.0812 which signifies that Bharat Immunologicals returns are very sensitive to returns on the market. as market goes up or down, Bharat Immunologicals is expected to follow.. Although it is essential to pay attention to Bharat Immunologicals historical returns, it is also good to be reasonable about what you can actually do with equity current trading patterns. Macroaxis philosophy in foreseeing future performance of any stock is to look not only at its past charts but also at the business as a whole, including all fundamental and technical indicators. To evaluate if Bharat Immunologicals Biologicals Corp Ltd expected return of 1.7091 will be sustainable into the future, we have found twenty-eight different technical indicators which can help you to check if the expected returns are sustainable. Use Bharat Immunologicals Sortino Ratio, Semi Variance and the relationship between Information Ratio and Value At Risk to analyze future returns on Bharat Immunologicals.
Investment Horizon     30 Days    Login   to change

Relative Risk vs. Return Landscape

If you would invest  2,330  in Bharat Immunologicals Biologicals Corp Ltd on March 26, 2017 and sell it today you would earn a total of  900.00  from holding Bharat Immunologicals Biologicals Corp Ltd or generate 38.63% return on investment over 30 days. Bharat Immunologicals Biologicals Corp Ltd is generating 1.7091% of daily returns and assumes 5.6792% volatility on return distribution over the 30 days horizon. Simply put, 55% of equities are less volatile than Bharat Immunologicals Biologicals Corp Ltd and 63% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
Benchmark  Embed    Risk (%) 
Assuming 30 trading days horizon, Bharat Immunologicals Biologicals Corp Ltd is expected to generate 10.85 times more return on investment than the market. However, the company is 10.85 times more volatile than its market benchmark. It trades about 0.3 of its potential returns per unit of risk. The NYSE is currently generating roughly 0.15 per unit of risk.

Operating Margin

Bharat Immunologicals Operating Margin
Based on recorded statements Bharat Immunologicals Biologicals Corp Ltd has Operating Margin of -5.13%. This is much lower than that of the sector, and significantly lower than that of Operating Margin industry, The Operating Margin for all stocks is over 1000% higher than the company.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
20 

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Bharat Immunologicals Biologicals Corp Ltd are ranked lower than 20 (%) of all global equities and portfolios over the last 30 days.

One Month Efficiency

Bharat Immunologicals Sharpe Ratio = 0.3009
Best
Portfolio
Best
Equity
Good Returns
Average ReturnsBIBCL
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Estimated Market Risk

 5.68
  actual daily
 
 45 %
of total potential
 
Market Risk score

Expected Return

 1.71
  actual daily
 
 38 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 0.3
  actual daily
 
 20 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average Bharat Immunologicals is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bharat Immunologicals by adding it to a well-diversified portfolio.